We are live on
!
Find out more
Holocene Advisors Portfolio holdings
AUM
$41.5B
1-Year Est. Return
42.97%
This Fund
S&P 500
This Quarter
Est. Return
+16.21%
1 Year Est. Return
+42.97%
3 Year Est. Return
+132.57%
5 Year Est. Return
+195.68%
10 Year Est. Return
–
AUM
$25.7B
AUM Growth
+$2.82B
(+12%)
Cap. Flow
-$314M
Cap. Flow
% of AUM
-1.22%
Top 10 Holdings %
Top 10 Hldgs %
15.35%
Holding
871
New
168
Increased
214
Reduced
287
Closed
191
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$327M |
| 2 |
AbbVie
ABBV
|
+$242M |
| 3 |
Dollar General
DG
|
+$229M |
| 4 |
Clorox
CLX
|
+$227M |
| 5 |
Texas Roadhouse
TXRH
|
+$196M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$363M |
| 2 |
Microsoft
MSFT
|
+$311M |
| 3 |
Colgate-Palmolive
CL
|
+$279M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$274M |
| 5 |
Kenvue
KVUE
|
+$266M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.7% |
| 2 | Consumer Discretionary | 17.67% |
| 3 | Technology | 17.2% |
| 4 | Consumer Staples | 11.96% |
| 5 | Industrials | 10.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Royal Caribbean
RCL
$87.6B
| $63.8M | 0.25% |
+492,955
| New | +$50.2M |
|
127
NOV
NOV
$6.95B
| $63.2M | 0.25% |
3,115,733
+2,879,260
| +1,218% | +$56.6M |
|
128
Eli Lilly
LLY
$1.04T
| $62.4M | 0.24% |
107,081
+15,275
| +17% | +$8.92M |
|
129
SLM Corp
SLM
$5.16B
| $62.2M | 0.24% |
3,255,467
+912,806
| +39% | +$13.8M |
|
|
NVO
130
Novo Nordisk
NVO
$197B
| $61.8M | 0.24% |
+596,996
| New | +$59M |
|
131
Biohaven
BHVN
$2.05B
| $61.7M | 0.24% |
1,441,361
-528,391
| -27% | -$16.4M |
|
132
IDEAYA Biosciences
IDYA
$3.47B
| $60.5M | 0.24% |
1,700,135
+667,204
| +65% | +$19.9M |
|
133
US Bancorp
USB
$100B
| $59.8M | 0.23% |
1,382,272
+413,625
| +43% | +$15.1M |
|
134
Texas Capital Bancshares
TCBI
$4.35B
| $59.4M | 0.23% |
919,022
-154,327
| -14% | -$8.89M |
|
135
Post Holdings
POST
$4.04B
| $59.4M | 0.23% |
674,292
+652,265
| +2,961% | +$55.4M |
|
136
Interactive Brokers
IBKR
$39.5B
| $58.2M | 0.23% |
2,808,400
+1,401,028
| +100% | +$28.7M |
|
137
MoonLake Immunotherapeutics
MLTX
$1.49B
| $58.1M | 0.23% |
961,330
+855,508
| +808% | +$44.1M |
|
|
P
138
Everpure Inc
P
$27.8B
| $58M | 0.23% |
1,627,449
-1,740,696
| -52% | -$61M |
|
139
Pinnacle Financial Partners Inc
PNFP
$16.2B
| $57.4M | 0.22% |
658,515
+217,963
| +49% | +$15.8M |
|
140
Globant
GLOB
$1.66B
| $57.2M | 0.22% |
+240,500
| New | +$49.1M |
|
141
Autoliv
ALV
$9.02B
| $55.2M | 0.22% |
500,803
+231,260
| +86% | +$23M |
|
142
Teva Pharmaceuticals
TEVA
$40.5B
| $54.9M | 0.21% |
5,258,195
+135,422
| +3% | +$1.26M |
|
143
Repligen
RGEN
$8.95B
| $54.8M | 0.21% |
+304,914
| New | +$47.5M |
|
144
Encompass Health
EHC
$11B
| $54.8M | 0.21% |
820,983
+188,175
| +30% | +$12.2M |
|
145
Elanco Animal Health
ELAN
$13.1B
| $54.6M | 0.21% |
3,664,122
-3,052,528
| -45% | -$34.6M |
|
146
Halliburton
HAL
$26.6B
| $52.3M | 0.2% |
+1,445,611
| New | +$55.6M |
|
147
Hershey
HSY
$36.1B
| $51.6M | 0.2% |
+276,847
| New | +$52.5M |
|
148
Enphase Energy
ENPH
$5.15B
| $51.4M | 0.2% |
+389,068
| New | +$41.3M |
|
149
Merck
MRK
$317B
| $51.3M | 0.2% |
+470,865
| New | +$48.9M |
|
150
Affirm
AFRM
$26.3B
| $50.3M | 0.2% |
1,024,443
-938,487
| -48% | -$27.1M |
|
Similar funds
DB
HF
Holocene Advisors's Q4 2023 Portfolio in Review
As of Q4 2023, Holocene Advisors held 871 positions worth $25.7B, up 12% from $22.8B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Holocene Advisors's Q4 2023 filing shows 168 new, 214 increased, 287 reduced and 191 closed positions. Its largest new stake was AbbVie: 1,660,493 shares worth $257M. The largest sale was Procter & Gamble, an estimated $363M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Technology.
- Holocene Advisors's largest Q4 2023 buy was AbbVie: 1,660,493 shares worth $257M.
- Holocene Advisors added most to Amazon in Q4 2023, an estimated $327M increase.
- Holocene Advisors's biggest Q4 2023 reduction was Microsoft, cutting an estimated $311M.
- Holocene Advisors fully exited Procter & Gamble in Q4 2023, selling an estimated $363M.
- Holocene Advisors's ten largest holdings make up 15% of its $25.7B portfolio in Q4 2023.
- Holocene Advisors opened 168 new positions and closed 191 in Q4 2023.
- Holocene Advisors's portfolio value rose 12% quarter-over-quarter to $25.7B.
Based on Holocene Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.